Search Results - "Pruszyński, Marek"
-
1
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer
Published in Molecules (Basel, Switzerland) (25-02-2020)“…It has been proven and confirmed in numerous repeated tests, that the use of a combination of several therapeutic methods gives much better treatment results…”
Get full text
Journal Article -
2
Adsorption of 137Cs on titanate nanostructures
Published in Journal of radioanalytical and nuclear chemistry (2014)“…Various types of sodium and potassium titanate nanostructures (nanotubes, nanofibers, nanoribbons, nanwires) were synthesized and characterized by X-ray…”
Get full text
Journal Article -
3
Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
Published in Nanomaterials (Basel, Switzerland) (18-04-2019)“…Highly localized radiotherapy with radionuclides is a commonly used treatment modality for patients with unresectable solid tumors. Herein, we propose a novel…”
Get full text
Journal Article -
4
Lead(II) complexes with amide-appended tetraazamacrocyclic ligands – Synthesis, structure, characterization and calculation studies
Published in Polyhedron (01-12-2020)“…Synthesis, structure and characterization of cationic lead(II) complexes with tetraazamacrocyclic ligands containing four amide groups are presented by means…”
Get full text
Journal Article -
5
Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I
Published in Materials (02-09-2020)“…Prostate cancer is the second most frequent malignancy in men worldwide. Unfortunately, current therapies often lead to the onset of metastatic…”
Get full text
Journal Article -
6
Crystal Structure, Spectroscopic Characterization, Antioxidant and Cytotoxic Activity of New Mg(II) and Mn(II)/Na(I) Complexes of Isoferulic Acid
Published in Materials (11-06-2021)“…The Mg(II) and heterometallic Mn(II)/Na(I) complexes of isoferulic acid (3-hydroxy-4-methoxycinnamic acid, IFA) were synthesized and characterized by infrared…”
Get full text
Journal Article -
7
Adsorption of [sup.137]Cs on titanate nanostructures
Published in Journal of radioanalytical and nuclear chemistry (01-09-2014)“…Various types of sodium and potassium titanate nanostructures (nanotubes, nanofibers, nanoribbons, nanwires) were synthesized and characterized by X-ray…”
Get full text
Journal Article -
8
Fe(III) and Cu(II) Complexes of Chlorogenic Acid: Spectroscopic, Thermal, Anti-/Pro-Oxidant, and Cytotoxic Studies
Published in Materials (01-10-2022)“…Complexes of chlorogenic acid (5-CQA) with copper(II) and iron(III) were synthesized in a solid state and examined by means of FT-IR, thermogravimetric, and…”
Get full text
Journal Article -
9
Trastuzumab-Modified Gold Nanoparticles Labeled with 211 At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
Published in Nanomaterials (Basel, Switzerland) (18-04-2019)“…Highly localized radiotherapy with radionuclides is a commonly used treatment modality for patients with unresectable solid tumors. Herein, we propose a novel…”
Get full text
Journal Article -
10
Astatine-211: production and availability
Published in Current radiopharmaceuticals (01-07-2011)“…The 7.2-h half life radiohalogen (211)At offers many potential advantages for targeted α-particle therapy; however, its use for this purpose is constrained by…”
Get more information
Journal Article -
11
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
Published in Nanomaterials (Basel, Switzerland) (20-10-2020)“…Barium ferrite nanoparticles (BaFeNPs) were investigated as vehicles for Ra radionuclide in targeted α-therapy. BaFe nanoparticles were labeled using a…”
Get full text
Journal Article -
12
Stability and in vivo behavior of Rh[16aneS4 -diol]211 At complex: A potential precursor for astatine radiopharmaceuticals
Published in Nuclear medicine and biology (01-05-2015)“…Abstract Introduction The heavy halogen211 At is of great interest for targeted radiotherapy because it decays by the emission of short-range, high-energy…”
Get full text
Journal Article -
13
Co(II) Complex of Quercetin–Spectral, Anti-/Pro-Oxidant and Cytotoxic Activity in HaCaT Cell Lines
Published in Applied sciences (01-10-2021)“…In this study a cobalt(II) complex of quercetin was synthetized in the solid state with the general formula Co(C15H9O7)2∙2H2O. The FT-IR, elemental analysis,…”
Get full text
Journal Article -
14
Preparation of Rh[16aneS 4 -diol] 211 At and Ir[16aneS 4 -diol] 211 At Complexes as Potential Precursors for Astatine Radiopharmaceuticals. Part I: Synthesis
Published in Bioconjugate chemistry (01-04-2008)“…The goal of this study was to evaluate a new approach that can be applied for labeling biomolecules with 211 At. Many astatine compounds that have been…”
Get full text
Journal Article -
15
211 At labelled Substance P (5–11) as potential radiopharmaceutical for glioma treatment
Published in Nuclear medicine and biology (01-10-2017)“…Abstract Introduction The purpose of the present work was to label Substance P (5–11) with211 At using a rhodium(III) complex with a bifunctional ligand –…”
Get full text
Journal Article -
16
Stability and in vivo behavior of Rh[16aneS4-diol]211At complex: A potential precursor for astatine radiopharmaceuticals
Published in Nuclear medicine and biology (01-05-2015)“…The heavy halogen 211At is of great interest for targeted radiotherapy because it decays by the emission of short-range, high-energy α-particles. However, many…”
Get full text
Journal Article -
17
131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
Published in Clinical cancer research (01-11-2017)“…Abstract Purpose: Camelid single-domain antibody-fragments (sdAb) have beneficial pharmacokinetic properties, and those targeted to HER2 can be used for…”
Get full text
Journal Article -
18
New measurement of excitation functions for (p,x) reactions on (nat)Mo with special regard to the formation of (95m)Tc, (96m+g)Tc, (99m)Tc and (99)Mo
Published in Applied radiation and isotopes (01-12-2010)“…Cross-sections for the proton induced reactions on natural molybdenum leading to (93m)Tc, (93m+g)Tc, (94)Tc, (94m)Tc, (95)Tc, (95m)Tc, (96m+g)Tc, (99m)Tc,…”
Get full text
Journal Article -
19
225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation
Published in Nuclear medicine and biology (01-05-2021)Get full text
Journal Article -
20
SSP-30 - 225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation
Published in Nuclear medicine and biology (01-05-2021)Get full text
Journal Article